Laboratory pipette with drop of liquid over glass test tubes in a science research lab

22 March 2022 - final results

The AIM-listed healthcare group has announced its annual results for the year to 31 December 2021 and these have shown further impressive growth.  Revenues for the year rose by 26% to £163.2m (2020: £129.8m) with underlying pre-tax profits rising by the same amount to £42.2m (2020: £33.5m).  Earnings per share on the same basis were 25% higher at 6.39p (2020: 5.11p) and the dividend has been raised by just 5% to 1.69p (2020: 1.61p).  Strong cash flow from operations has meant that net debt has . . .

This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.

Already a member, log in HERE.